Adverum Biotechnologies Announces Upcoming Data Presentations at ASGCT 2023 including Data on a New…
<!-- Name:DistributionId Value:8830389 -->
<!--…
Read More...
Read More...
Browsing Tag
ASGCT
Dyne Therapeutics to Present New Preclinical Data at ASGCT Annual Meeting Demonstrating FORCE™…
<!-- Name:DistributionId Value:8830457 -->
<!--…
Read More...
Read More...
uniQure Announces Major Presence at Upcoming American Society of Gene and Cell Therapy (ASGCT)…
<!-- Name:DistributionId Value:8830430 -->
<!--…
Read More...
Read More...
Preclinical Proof-of-Concept Data Supporting Future Clinical Development of Two New Cell Therapies…
- New next-gen SPEAR T-cells (ADP-A2M4N7X19) designed to enhance depth and durability of clinical response demonstrated…
Read More...
Read More...
Codexis to Present Data Highlighting Three Gene Therapy Programs at the ASGCT 25th Annual Meeting
REDWOOD CITY, Calif., May 02, 2022 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering…
Read More...
Read More...
uniQure Announces Multiple Presentations at Upcoming American Society of Gene and Cell Therapy…
LEXINGTON, Mass. and AMSTERDAM, May 02, 2022 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy…
Read More...
Read More...
4D Molecular Therapeutics Presents Non-Human Primate Preclinical Data at ASGCT on the 4D-150 Product…
4D-150 designed as an intravitreal gene therapy with dual transgenes expressing aflibercept and VEGF-C RNAi for the…
Read More...
Read More...